These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8510099

  • 1. Transformation of monoamine oxidase-B primary amine substrates into time-dependent inhibitors. Tertiary amine homologues of primary amine substrates.
    Ding CZ, Lu X, Nishimura K, Silverman RB.
    J Med Chem; 1993 Jun 11; 36(12):1711-5. PubMed ID: 8510099
    [Abstract] [Full Text] [Related]

  • 2. Transformation of heterocyclic reversible monoamine oxidase-B inactivators into irreversible inactivators by N-methylation.
    Ding CZ, Silverman RB.
    J Med Chem; 1993 Nov 12; 36(23):3606-10. PubMed ID: 8246228
    [Abstract] [Full Text] [Related]

  • 3. New analogues of N-(2-aminoethyl)-4-chlorobenzamide (Ro 16-6491). Some of the most potent monoamine oxidase-B inactivators.
    Annan N, Silverman RB.
    J Med Chem; 1993 Nov 26; 36(24):3968-70. PubMed ID: 8254625
    [Abstract] [Full Text] [Related]

  • 4. Simple, potent, and selective pyrrole inhibitors of monoamine oxidase types A and B.
    Silvestri R, La Regina G, De Martino G, Artico M, Befani O, Palumbo M, Agostinelli E, Turini P.
    J Med Chem; 2003 Mar 13; 46(6):917-20. PubMed ID: 12620068
    [Abstract] [Full Text] [Related]

  • 5. Syntheses of amino nitrones. Potential intramolecular traps for radical intermediates in monoamine oxidase-catalyzed reactions.
    Zhong B, Lu X, Silverman RB.
    Bioorg Med Chem; 1998 Dec 13; 6(12):2405-19. PubMed ID: 9925298
    [Abstract] [Full Text] [Related]

  • 6. SAR studies of fluorine-substituted benzylamines and substituted 2-phenylethylamines as substrates and inactivators of monoamine oxidase B.
    Silverman RB, Hawe WP.
    J Enzyme Inhib; 1995 Dec 13; 9(3):203-15. PubMed ID: 8847600
    [Abstract] [Full Text] [Related]

  • 7. Mechanism for reactivation of N-cyclopropylbenzylamine-inactivated monoamine oxidase by amines.
    Yamasaki RB, Silverman RB.
    Biochemistry; 1985 Nov 05; 24(23):6543-50. PubMed ID: 4084537
    [Abstract] [Full Text] [Related]

  • 8. Stereoisomers of allenic amines as inactivators of monoamine oxidase type B. Stereochemical probes of the active site.
    Smith RA, White RL, Krantz A.
    J Med Chem; 1988 Aug 05; 31(8):1558-66. PubMed ID: 3397993
    [Abstract] [Full Text] [Related]

  • 9. Parameters for Irreversible Inactivation of Monoamine Oxidase.
    Ramsay RR, Basile L, Maniquet A, Hagenow S, Pappalardo M, Saija MC, Bryant SD, Albreht A, Guccione S.
    Molecules; 2020 Dec 13; 25(24):. PubMed ID: 33322203
    [Abstract] [Full Text] [Related]

  • 10. Inhibitor design for monoamine oxidases.
    Ramsay RR.
    Curr Pharm Des; 2013 Dec 13; 19(14):2529-39. PubMed ID: 23116392
    [Abstract] [Full Text] [Related]

  • 11. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
    La Regina G, Silvestri R, Artico M, Lavecchia A, Novellino E, Befani O, Turini P, Agostinelli E.
    J Med Chem; 2007 Mar 08; 50(5):922-31. PubMed ID: 17256833
    [Abstract] [Full Text] [Related]

  • 12. [Multiplicity of mitochondrial monoamine exidases and ways of selective blocking of the enzyme activity].
    Severina IS.
    Biokhimiia; 1976 Jul 08; 41(6):955-67. PubMed ID: 829219
    [Abstract] [Full Text] [Related]

  • 13. Effect of the locus of the oxygen atom in amino ethers on the inactivation of monoamine oxidase B.
    Yelekçi K, Silverman RB.
    J Enzyme Inhib; 1998 Feb 08; 13(1):31-9. PubMed ID: 9879512
    [Abstract] [Full Text] [Related]

  • 14. Structural aspects of monoamine oxidase and its reversible inhibition.
    Wouters J.
    Curr Med Chem; 1998 Apr 08; 5(2):137-62. PubMed ID: 9481038
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Design, synthesis and bioevalucation of novel 2,3-dihydro-1H-inden-1-amine derivatives as potent and selective human monoamine oxidase B inhibitors based on rasagiline.
    Xiao X, Zhang XX, Zhan MM, Cheng K, Li S, Xie Z, Liao C.
    Eur J Med Chem; 2018 Feb 10; 145():588-593. PubMed ID: 29339253
    [Abstract] [Full Text] [Related]

  • 17. Novel polyamine analogues: from substrates towards potential inhibitors of monoamine oxidases.
    Bonaiuto E, Milelli A, Cozza G, Tumiatti V, Marchetti C, Agostinelli E, Fimognari C, Hrelia P, Minarini A, Di Paolo ML.
    Eur J Med Chem; 2013 Feb 10; 70():88-101. PubMed ID: 24140951
    [Abstract] [Full Text] [Related]

  • 18. Inactivation of monoamine oxidase B by analogues of the anticonvulsant agent milacemide (2-(n-pentylamino)acetamide).
    Nishimura K, Lu X, Silverman RB.
    J Med Chem; 1993 Feb 19; 36(4):446-8. PubMed ID: 8474100
    [Abstract] [Full Text] [Related]

  • 19. The interaction of monoamine oxidases with tertiary amines.
    Singer TP, Ramsay RR.
    Biochem Soc Trans; 1991 Feb 19; 19(1):211-5. PubMed ID: 2037153
    [No Abstract] [Full Text] [Related]

  • 20. Mechanism-based inactivation of mitochondrial monoamine oxidase by N-(1-methylcyclopropyl)benzylamine.
    Silverman RB, Yamasaki RB.
    Biochemistry; 1984 Mar 13; 23(6):1322-32. PubMed ID: 6712946
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.